AMG:ETR
Amgen
401,35 €
arrow_upward
+1,74%(+6,85) 1K
27-okt, 17:35:30 (GMT+1) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoAMG tikeri uchun statistika yaratilmoqda...
Ochish
397,75 €
Yuqori
402,00 €
Past
394,65 €
Bozor kapitali
241,54 mlrd
Oʻrtacha hajm
524,00
Hajmi
1,30 ming
52 haftalik eng yuqori
402,00 €
52 haftalik eng past
247,65 €
Xodimlar soni
32 ming
Ochish
397,75 €
Yuqori
402,00 €
Past
394,65 €
Bozor kapitali
241,54 mlrd
Oʻrtacha hajm
524,00
Hajmi
1,30 ming
52 haftalik eng yuqori
402,00 €
52 haftalik eng past
247,65 €
Xodimlar soni
32 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Investor's Business Daily
·
13 daqiqa oldin
Dow Jones Biotech Giant Amgen Breaks Out Ahead Of Q3 Earnings Results
The Motley Fool
·
2 soat oldin
Amgen vs. Novo Nordisk: Which Healthcare Giant's Stock Is a Better Buy in 2026?
Investing.com
·
3 soat oldin
Amgen stock may move 4.3% on earnings release next week
Seeking Alpha
·
5 soat oldin
Amgen Stock: A Biotech Bargain Heading Into Q3 Earnings (NASDAQ:AMGN)
Profil
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Amgen haqida
CEORobert A. Bradway
Xodimlar soni31,5 ming
Asos solingan1980
Bosh ofislarTauzand-Oks, Kaliforniya, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytamgen.com